News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
325โ€“360
Matches
1388
Sources here
21
Companies here
17
Search results Stored financial headlines

Active search

1388 matching headlines

Ticker or company: ANNMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Crossmark Global Holdings Inc. Buys 3,075 Shares of Parker-Hannifin Corporation $PH

Crossmark Global Holdings Inc. increased its stake in Parker-Hannifin Corporation by 14.1% in the second quarter, purchasing an additional 3,075 shares, bringing its total holdings to 24,808 shares valued at $24.3 million. Parker-Hannifin recently reported strong quarterly earnings, beating analyst estimates with $9.27 EPS โ€ฆ

PH main company
Sharemaestro market context Trend signal active 52 weeks +33.1% ยท Next-week setup positive 59.5% PH stored weekly price path from 29 Aug 2025 to 21 Aug 2026

BTC Capital Management Inc. Buys 7,814 Shares of Parker-Hannifin Corporation $PH

BTC Capital Management Inc. significantly increased its stake in Parker-Hannifin Corporation, purchasing an additional 7,814 shares, bringing its total holdings to 15,950 shares valued at $15.6 million. Analysts maintain a "Moderate Buy" consensus for PH with an average price target of $1,091.38. The company โ€ฆ

PH main company
Sharemaestro market context Trend signal active 52 weeks +33.1% ยท Next-week setup positive 59.5% PH stored weekly price path from 29 Aug 2025 to 21 Aug 2026

Aveanna hits 52-week high after Q2 beat, guidance hike

[Close up image of wooden cubes with alphabet Q2 on office desk.] mohd izzuan Shares of Aveanna Healthcare (AVAH [https://seekingalpha.com/symbol/AVAH]) reached a new 52-week high on Thursday after the home healthcare provider reported better-than-expected Q2 2026 financials and raised its full-year outlook above the โ€ฆ

AVAH main company
Sharemaestro market context Trend signal active 52 weeks +64.5% AVAH stored weekly price path from 29 Aug 2025 to 21 Aug 2026

CCO Stock Stalls As Traders Weigh Heavy Debt And Tight Range

Clear Channel Outdoor Holdings Inc. (CCO) stock is trading down amidst negative sentiment regarding its debt restructuring. Despite strong gross margins, the company faces significant long-term debt and negative equity, leading to low volatility and consolidation in its stock price. Traders are closely watching โ€ฆ

CCO main company
Sharemaestro market context Trend signal active 52 weeks +91.9% ยท Next-week setup negative 42.7% CCO stored weekly price path from 29 Aug 2025 to 21 Aug 2026

AleAnna, Inc. Reports Second Quarter 2026 Results

AleAnna, Inc. reported strong financial and operational results for the second quarter of 2026, marking its fifth consecutive quarter of positive Adjusted EBITDA and net income. The company achieved $3.8 million in net income and $4.1 million in Adjusted EBITDA, primarily driven by production โ€ฆ

ANNA main company
Sharemaestro market context Price below Trend Line 52 weeks -29.9% ANNA stored weekly price path from 29 Aug 2025 to 21 Aug 2026

Horace Mann Educatorsโ€™s Q2 Earnings Call: Our Top 5 Analyst Questions

Horace Mann Educators's Q2 Earnings Call: Our Top 5 Analyst Questions Horace Mann Educators' results for Q2 reflected steady execution, with the company meeting Wall Street's revenue expectations and posting non-GAAP profit meaningfully above consensus. Management pointed to disciplined underwriting in Property & Casualty โ€ฆ

HMN main company
Sharemaestro market context Trend signal active 52 weeks +13.5% HMN stored weekly price path from 29 Aug 2025 to 21 Aug 2026

IM Cannabis reports Q2 2026 revenue drop and $4.4M net loss amid operational challenges.

IM Cannabis Corp. reported a significant revenue decrease in Q2 2026, falling to $7.6 million from $12.7 million in Q2 2025, alongside a net loss of $4.4 million. The company is facing ongoing financial challenges, including increased operating losses and a growing shareholders' deficit. โ€ฆ

IMCC main company
Sharemaestro market context Price below Trend Line 52 weeks -95.1% ยท Next-week setup negative 39.1% IMCC stored weekly price path from 29 Aug 2025 to 21 Aug 2026

IM Cannabis Corp. Announces Second Quarter and First Half 2026 Financial Results

IM Cannabis Corp. (IMCC) announced its financial results for the second quarter and first half of 2026, revealing a decrease in revenue and an increase in net loss compared to the same periods in 2025. For the first half of 2026, revenue was $16.3 โ€ฆ

IMCC main company
Sharemaestro market context Price below Trend Line 52 weeks -95.1% ยท Next-week setup negative 39.1% IMCC stored weekly price path from 29 Aug 2025 to 21 Aug 2026

Insider for ANNX (ANNX) plans sale of 2,000 shares after option exercise

An individual affiliated with Annexon, Inc. (ANNX) has filed a Form 144 notice indicating an intent to sell 2,000 shares of common stock on August 13, 2026. These shares will be acquired through a same-day stock option exercise for cash. The filing also reports โ€ฆ

ANNX main company
Sharemaestro market context Price below Trend Line 52 weeks +146.1% ยท Next-week setup negative 42.5% ANNX stored weekly price path from 29 Aug 2025 to 21 Aug 2026

IM Cannabis Corp. (IMCC) Stock Falls on Q2 2026 Earnings

IM Cannabis Corp. (IMCC) reported a significant decline in Q2 2026 revenue, down 42.8% year-over-year to $5.4 million, with a net loss of $3.1 million. This financial performance led to a 1.9% drop in the stock price after market close. Institutional investors showed mixed โ€ฆ

IMCC main company
Sharemaestro market context Price below Trend Line 52 weeks -95.1% ยท Next-week setup negative 39.1% IMCC stored weekly price path from 29 Aug 2025 to 21 Aug 2026

IM Cannabis (Nasdaq: IMCC) revenue drops as losses mount and going concern risk cited

IM Cannabis Corp. (IMCC) reported a significant revenue drop and mounting losses for the first half of 2026, leading management to flag substantial doubt about the company's ability to continue as a going concern. Revenue fell to $16.268 million from $25.196 million year-over-year, with โ€ฆ

IMCC main company
Sharemaestro market context Price below Trend Line 52 weeks -95.1% ยท Next-week setup negative 39.1% IMCC stored weekly price path from 29 Aug 2025 to 21 Aug 2026

Aveanna Eyes Home Health, Hospice M&A While Executing Preferred Payer Strategy

Aveanna Healthcare Holdings (Nasdaq: AVAH) has surpassed its preferred payer goals and intends to expand its home health and hospice segment through strategic acquisitions. The company updated its organic growth rate for home health and hospice to 8-10% and anticipates achieving double-digit annual revenue โ€ฆ

AVAH main company
Sharemaestro market context Trend signal active 52 weeks +64.5% AVAH stored weekly price path from 29 Aug 2025 to 21 Aug 2026

A Quick Look at Today's Ratings for Annexon(ANNX.US), With a Forecast Between $8 to $27

This article provides an overview of Annexon (ANNX.US) stock ratings from four analysts in the last quarter, with a consensus price target ranging from $8 to $27. The analysts show a generally bullish sentiment, reflected in their diverse ratings and price targets, indicating varying โ€ฆ

ANNX main company
Sharemaestro market context Price below Trend Line 52 weeks +146.1% ยท Next-week setup negative 42.5% ANNX stored weekly price path from 29 Aug 2025 to 21 Aug 2026

Curaleaf CEO Defends Hostile Aurora Bid: โ€œWe Wanted To Be Friendlyโ€

Curaleaf CEO Defends Hostile Aurora Bid: "We Wanted To Be Friendly" - Moby THE GIST Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap โ€ฆ

ACB main company ACB main company
Sharemaestro market context Price above Trend Line 52 weeks -26.9% ยท Next-week setup negative 42.8% ACB stored weekly price path from 29 Aug 2025 to 21 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context